8 Results
Measuring Innovation: Laboratory Infrastructure to Deliver Essential HIV Clinical Trial Results
HIV clinical trials network laboratory functions will continue to evolve to align with scientific priorities and research approaches.
Gene Signature at Birth Predicts Sepsis in Newborns Before Signs Appear
A four-gene signature in newborns’ blood at birth predicts before symptom onset whether a baby will develop neonatal sepsis during the first week of life.
Can Improved Tests Speed Up Treatment for Antibacterial Resistant Infections?
An ongoing NIAID-supported trial is testing whether rapid tests for antibiotic susceptibility can improve patient outcomes.
Fungal Disease Awareness Week—Fighting Fungi at NIAID
Fungal Disease Awareness Week spotlights clinical trials of improved treatments for fungal infections, such as better use of antibiotics and treatment combinations.
Sexually Transmitted Infections—A Closer Look at NIAID Research
Sexually transmitted infections (STIs) are caused by bacteria, viruses, or parasites. NIAID supports research across the spectrum from basic to clinical science to develop effective diagnostic, preventive and therapeutic approaches to STIs in alignment with the National STI Strategic Plan. In recognition of National STI Awareness Week, NIAID shares a snapshot of new projects and recent scientific advances in STI research.
Doxy-PEP, HIV Vaccines and Community-Engaged Research: Discussions with Carl Dieffenbach and LaRon Nelson at CROI 2024 (VIDEO)
During the first full day of presentations at the 2024 Conference on Retroviruses and Opportunistic Infections, HIV.gov spoke with Carl Dieffenbach, Ph.D., director of NIAID’s Division of AIDS, and LaRon Nelson, Ph.D., R.N., F.N.P., F.N.A.P., F.N.Y.A.M., F.A.A., professor and associate dean at the Yale School of Nursing. They discussed Doxy-PEP for STI prevention, HIV vaccines, community engagement in research, and more. Watch their discussions.
NIAID-Funded Study Traces Evolution of Malaria Drug Resistance in E. Africa
A new NIAID-funded study shows how inconsistent malaria control measures in East Africa could be aiding the emergence of drug-resistant mutations in the primary parasite that causes malaria.
NIAID-led Work Identifies Bacteria Signaling for Nerve Repair in Mice
A team of NIAID-led researchers has identified a mechanism in mice in which the immune system and commensal bacteria help repair damaged sensory neurons within the skin. They hope their findings could lead to therapies that stimulate recovery in people following skin injury and limit damage from chemotherapy and chronic diseases.
